Yann Mazabraud - 09 Feb 2024 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
EVP, Head of International
Signature
/s/ Hunter Smith, Attorney-in-Fact for Yann Mazabraud
Issuer symbol
RYTM
Transactions as of
09 Feb 2024
Net transactions value
-$129,597
Form type
4
Filing time
13 Feb 2024, 20:49:16 UTC
Previous filing
18 Apr 2023
Next filing
21 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise +3,438 +90% 7,265 09 Feb 2024 Direct F1
transaction RYTM Common Stock Options Exercise +2,031 +28% 9,296 11 Feb 2024 Direct F1
transaction RYTM Common Stock Sale $81,900 -1,594 -17% $51.38 7,702 12 Feb 2024 Direct F2
transaction RYTM Common Stock Sale $47,697 -957 -12% $49.84 6,745 13 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Restricted Stock Units Options Exercise $0 -3,438 -33% $0.000000 6,874 09 Feb 2024 Common Stock 3,438 Direct F1, F3
transaction RYTM Restricted Stock Units Options Exercise $0 -2,031 -50% $0.000000 2,031 11 Feb 2024 Common Stock 2,031 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
F3 The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.
F4 The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.